Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 244 publications
Circulating tumor DNA concentration at diagnosis is a modifiable prognostic factor for distant metastatic recurrence in patients with high-risk breast cancer receiving neoadjuvant therapy.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2026
Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk ERBB2-Negative Breast Cancer: The I-SPY2 Randomized Clinical Trial.
Journal: JAMA oncology
Published: July 30, 2026
Neoadjuvant Palbociclib Treatment Impacts Cell Cycle Progression of DCIS.
Journal: Cancers
Published: July 18, 2026
The FYI on MRI: Protocol for a randomized, parallel-group superiority trial of a multilevel decision support intervention to increase informed decision-making about screening breast MRI among high-risk black and Latina women.
Journal: Contemporary clinical trials
Published: February 09, 2026
Real-world clinical outcomes of patients with early-stage TNBC and BRCAm who were treated with adjuvant capecitabine in the United States.
Journal: Breast cancer research and treatment
Published: January 09, 2026
Longitudinal Quality of Life in Adults with Metastatic Breast Cancer: The Impact of Between- and Within- Person Changes in Symptoms and Positive Affect.
Journal: Research square
Published: December 03, 2025
Patient-reported outcomes from the TBCRC 022 study of neratinib and ado-trastuzumab emtansine for HER2-positive breast cancer brain metastases.
Journal: Breast (Edinburgh, Scotland)
Published: November 11, 2025
Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.
Journal: JNCI cancer spectrum
Published: October 20, 2025
Interaction of endocrine therapy for breast cancer with APOE4 status on cognition over 5-year follow-up.
Journal: JNCI cancer spectrum
Published: October 02, 2025
Last Updated: 09/26/2026